Abstract
Agilent Technologies recognized by Frost & Sullivan as 2013 Laboratory Analytical Instrumentation Company of the Year in China. Verisante Technology, Inc. announces study on nasopharnygeal cancer in China. ICON signs collaboration agreement with the Taiwan National Centre of Excellence for clinical trials and research. MicuRx completes $25 million Series B financing. Connecticut's CURE network welcomes HLK, its first Chinese member company. 2013 BIO Convention in China to connect biotech industry to the world's 2nd largest biopharmaceutical market. Partner State Key Laboratory of Pharmaceutical Biotechnology opened at HKU. Amgen and ShanghaiTech University announce plans for Amgen China R&D center to open on ShanghaiTech campus. CANbridge Life Sciences enters into agreement with Azaya Therapeutics to develop ATI-1123 for lung cancer in China and North Asia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
